The IMNOVID brand, founded in 2011 (United States), from
126 sister brands
and 17477 competing brands.
IMNOVID is owned by Celgene, listed on the stock exchange of New York
IMNOVID is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.